Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial (PAUSE-SCD): rationale and study design.

Chen M, Wu S, Yao Y, Jiang J, Jiang C, Xue Y, Zhan X, Hu H, Fu G, Gu K, Liu H, Ding L, Jiang R, Chung FP, Lin YJ, Hori Y, Komatsu Y, Ueda A, Soejima K, Kim YH, Nogami A, Nakahara S, Chen SA, Tung R; PAUSE-SCD investigators.

J Interv Card Electrophysiol. 2019 Mar 19. doi: 10.1007/s10840-019-00535-w. [Epub ahead of print]

PMID:
30891654
2.

Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.

3.

Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.

AbdelWahab A, Sapp J.

Curr Cardiol Rep. 2017 Sep 13;19(11):105. doi: 10.1007/s11886-017-0924-0. Review.

PMID:
28900864
4.

Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death [Internet].

Uhlig K, Balk EM, Earley A, Persson R, Garlitski AC, Chen M, Lamont JL, Miligkos M, Avendano EE.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun 26.

5.

Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?

Wichter T, Paul TM, Eckardt L, Gerdes P, Kirchhof P, Böcker D, Breithardt G.

Herz. 2005 Mar;30(2):91-101. Review.

PMID:
15875097
6.

Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.

Teo WS, Kam R, Tan A.

Ann Acad Med Singapore. 1998 Mar;27(2):248-54. Review.

PMID:
9663319
7.

Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials.

Patel D, Hasselblad V, Jackson KP, Pokorney SD, Daubert JP, Al-Khatib SM.

J Interv Card Electrophysiol. 2016 Mar;45(2):111-7. doi: 10.1007/s10840-015-0083-4. Epub 2015 Dec 22. Review.

PMID:
26695501
8.

Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.

Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS; VTACH study group.

Lancet. 2010 Jan 2;375(9708):31-40. doi: 10.1016/S0140-6736(09)61755-4.

PMID:
20109864
9.

Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.

Santangeli P, Tung R, Xue Y, Chung FP, Lin YJ, Di Biase L, Zhan X, Lin CY, Wei W, Mohanty S, Burkhardt DJ, Zado ES, Callans DJ, Marchlinski FE, Wu S, Chen SA, Natale A.

JACC Clin Electrophysiol. 2019 Jan;5(1):55-65. doi: 10.1016/j.jacep.2018.09.019. Epub 2018 Nov 28.

PMID:
30678787
10.

Catheter ablation of ventricular tachycardia. From indication to three-dimensional mapping technology.

Eckardt L, Breithardt G.

Herz. 2009 May;34(3):187-96. doi: 10.1007/s00059-009-3247-0. Review.

PMID:
19444402
11.

[Non-pharmacologic prevention of sudden cardiac death].

Jurkovicová O, Cagán S.

Bratisl Lek Listy. 1997 Jul-Aug;98(7-8):423-39. Review. Slovak.

PMID:
9471337
12.

Outcomes of patients admitted with ventricular arrhythmias and sudden cardiac death in the United States.

Viles-Gonzalez JF, Arora S, Deshmukh A, Atti V, Agnihotri K, Patel N, Dave M, Anter E, Garcia F, Santangeli P, Goldberger JJ, Dukkipati S, d'Avila A, Natale A, Di Biase L.

Heart Rhythm. 2019 Mar;16(3):358-366. doi: 10.1016/j.hrthm.2018.09.007. Epub 2018 Sep 18.

PMID:
30236610
13.

Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.

Bunch TJ, Weiss JP, Crandall BG, Day JD, May HT, Bair TL, Osborn JS, Mallender C, Fischer A, Brunner KJ, Mahapatra S.

Heart Rhythm. 2014 Apr;11(4):533-40. doi: 10.1016/j.hrthm.2013.12.014. Epub 2013 Dec 11.

PMID:
24333283
14.

Ventricular tachycardia and sudden death after primary PCI-reperfusion therapy: impact on primary prevention of sudden cardiac death.

Paranskaya L, Akin I, Chatterjee T, Ritz A, Paranski P, Rehders T, Ince H, Schneider H, Nienaber CA, Bänsch D.

Herzschrittmacherther Elektrophysiol. 2011 Dec;22(4):243-8. doi: 10.1007/s00399-011-0160-z.

PMID:
22124800
15.

ICD lead proarrhythmia cured by lead extraction.

Lee JC, Epstein LM, Huffer LL, Stevenson WG, Koplan BA, Tedrow UB.

Heart Rhythm. 2009 May;6(5):613-8. doi: 10.1016/j.hrthm.2009.01.039. Epub 2009 Feb 4.

PMID:
19328039
16.

Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.

Acosta J, Cabanelas N, Penela D, Fernández-Armenta J, Andreu D, Borràs R, Korshunov V, Cabrera M, Vasanelli F, Arbelo E, Guasch E, Martínez M, Tolosana JM, Mont L, Berruezo A.

Europace. 2017 Jun 1;19(6):976-982. doi: 10.1093/europace/euw096.

PMID:
27353322
17.

Prophylactic catheter ablation for the prevention of defibrillator therapy.

Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME.

N Engl J Med. 2007 Dec 27;357(26):2657-65.

18.

MAGNETIC VT study: a prospective, multicenter, post-market randomized controlled trial comparing VT ablation outcomes using remote magnetic navigation-guided substrate mapping and ablation versus manual approach in a low LVEF population.

Di Biase L, Tung R, Szili-Torok T, Burkhardt JD, Weiss P, Tavernier R, Berman AE, Wissner E, Spear W, Chen X, Neužil P, Skoda J, Lakkireddy D, Schwagten B, Lock K, Natale A; MAGNETIC VT investigators.

J Interv Card Electrophysiol. 2017 Apr;48(3):237-245. doi: 10.1007/s10840-016-0217-3. Epub 2017 Jan 7.

PMID:
28064433
19.

[Indications for catheter ablation of ventricular tachycardia].

Deneke T, Israel CW, Krug J, Nentwich K, Müller P, Mügge A, Schade A.

Dtsch Med Wochenschr. 2013 Sep;138(39):1952-6. doi: 10.1055/s-0033-1349563. Epub 2013 Sep 17. Review. German.

PMID:
24046136
20.

Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.

Al-Khatib SM, Daubert JP, Anstrom KJ, Daoud EG, Gonzalez M, Saba S, Jackson KP, Reece T, Gu J, Pokorney SD, Granger CB, Hess PL, Mark DB, Stevenson WG.

J Cardiovasc Electrophysiol. 2015 Feb;26(2):151-7. doi: 10.1111/jce.12567. Epub 2014 Nov 30.

PMID:
25332150

Supplemental Content

Support Center